Update: Hikma Pharmaceuticals Closes Xellia Acquisition, Valued At $135 Million
Hikma Pharmaceuticals has completed the acquisition of Xellia.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
